Yanxia Liu, Yunong Li, Ruoqiu Fu, et al. Effects of doxorubicin on cofilin interacting proteins in nucleus of breast cancer cells through comparative proteomics[J]. Journal of Third Military Medical University, 2017, 39(6): 522-528.
DOI:
Yanxia Liu, Yunong Li, Ruoqiu Fu, et al. Effects of doxorubicin on cofilin interacting proteins in nucleus of breast cancer cells through comparative proteomics[J]. Journal of Third Military Medical University, 2017, 39(6): 522-528. DOI: 10.16016/j.1000-5404.201611024.
Effects of doxorubicin on cofilin interacting proteins in nucleus of breast cancer cells through comparative proteomics
To determine the effects of doxorubicin on cofilin interacting proteins in the nucleus of breast cancer cells.
Methods
2
The expression of cofilin in the nucleus was evaluated by Western blotting. After immunoprecipitation
the differences of cofilin interacting proteins in the nucleus between the controls and doxorubicin-treated cells were determined by comparative proteomics. The effects of doxorubicin on cell cycle were determined by flow cytometry.
Results
2
Doxorubicin treatment resulted in an increase of cofilin level in the nucleus of MDA-MB-231 cells in dose-and time-dependent manner. Compared with the controls
doxorubicin treatment also resulted in a decreases of the types of cofilin interacting proteins including protein binding proteins
structural molecule activity proteins
cytos
keleton proteins
nucleic acid binding proteins
and ribosome proteins (109
60
45
76
and 34
vs
79
32
20
56
and 16
respectively). Furthermore
doxorubicin treatment led to cell cycle arrest at S/G
2
phase in a dose-dependent manner and the percentage of cells at G
1
phase was declined from (45.92±4.57)% to (10.50±0.83)% (
P
<
0.01).
Conclusion
2
Doxorubicin treatment increases the accumulation of cofilin in the nuclear
decreases the types of cofilin interacting proteins
and finally leads to cell cycle arrest at S/G2 phase.
Li D L, Zhou Y B, Han C, et al. Small interfering rna targeting stat3 enhances the drug susceptibility of adriamycin in breast cancer cells[J]. Chin Pharm J, 2016, 51(11): 896-903. DOI: 10. 11669 /cpj. 2016. 11. 007
Ciftci K, Su J, Trovitch P B. Growth factors and chemotherapeutic modulation of breast cancer cells[J]. J Pharm Pharmacol, 2003, 55(8): 1135-1141. DOI: 10.1211/002235703322277177
Zhao M, Jiang B, Gao F H. Small molecule inhibitors of STAT3 for cancer therapy[J]. Curr Med Chem, 2011, 18(26): 4012-4018. DOI: 10.2174/092986711796957284
Li Q, Wang X W, Song B. Dysregulation effect of microRNA-21 gene on drug resistance in ADM-resistant MCF-7 breast cancer cells[J]. Chinese Journal of Cancer Prevention&Treatment, 2012, 19(3): 188-191.
Lacerda L, Pusztai L, Woodward W A. The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches[J]. Drug Resist Updat, 2010, 13(4/5): 99-108. DOI: 10.1016/j.drup.2010.08.001
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J]. CA Cancer J Clin, 2012, 62(1): 10-29. DOI: 10.3322/caac.20138
Bober P, Alexovic M, Talian I, et al. Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line[J]. J Cancer Res Clin Oncol, 2017, 143(1): 35-42. DOI: 10.1007/s00432-016-2259-4
Zhang C H, Tu X Y, Xiong S P, et al. Screening for serum differentially-expressed proteins Gegen Qin Lian decoctionin treating insulin resistance with proteomics technology[J ] . Traditional Chinese Drug Research & Clinical Pharmacology, 2016, 27(1): 81-85. DOI: 10.3969/j.issn.1003-9783.2016.01.018
Grzanka D, Marszalek A, Izdebska M, et al. Actin cytoskeleton reorganization correlates with cofilin nuclear expression and ultrastructural changes in cho aa8 cell line after apoptosis and mitotic catastropheinduction by doxorubicin[J]. Ultrastruct Pathol, 2011, 35(3): 130-138. DOI: 10.3109/01913123.2010.548113
Munsie L N, Desmond C R, Truant R. cofilin nuclear-cytoplasmic shuttling affects cofilin-actin rod formation during stress[J]. J Cell Sci, 2012, 125(Pt 17): 3977-3988. DOI: 10.1242/jcs.097667
A novel estrogen receptor expression stratification (low/moderate/high) based on Chinese population provides more accurate prognosis prediction for HR+/HER2- early breast cancer patients
Downregulating RRM2B expression to increase radiation sensitivity of breast cancer cells
Characteristics of body image and their relationship with perceived stress, self-compassion and implicit attitudes in female breast cancer patients
Prognostic factors for breast cancer brain metastasis and primary construction of a prediction model
LINC00294 promotes proliferation, invasion, and migration of breast cancer cells via AKT/mTOR/HIF-1α pathway
Related Author
WANG Chengfang
ZHOU Yuqin
ZHANG Yanling
QI Xiaowei
ZHANG Yi
李安琪
孙海燕
祁孟瑶
Related Institution
Department of Breast and Thyroid Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Breast Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Clinical Laboratory, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Military Nutrition and Food Hygiene, Chongqing Key Laboratory of Nutrition and Food Safety, Chongqing Center of Medical Nutrition, Faculty of Military Preven tive Medicine, Army Medical University (Third Military Medical University)